Trial Search Results

Cyberknife Precision Radiation Delivery System for Tumors of the Spine

The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: Stereotactic radiosurgery

Phase:

Phase 1/Phase 2

Eligibility


Inclusion Criteria:- Intra-axial, extra-axial, or vertebral spinal lesion

   - Age > 5

   - Histologic confirmation of malignant primary lesion or radiographic diagnosis of
   benign or vascular spinal lesion

   - No rapidly deteriorating symptoms of spinal cord compression

   - No instability of the spine

   - Life expectancy > 6 months

Exclusion Criteria:- Patients without tumors of the spine

- Patients younger than 5 years old

Ages Eligible for Study

5 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Laurie Tupper
6507361694
Not Recruiting